Gujarat Kidney & Super Speciality Ltd
Incorporated in 2019, Gujarat Kidney and Super Speciality Limited specializes in providing multispeciality healthcare services.[1]
- Market Cap ₹ 836 Cr.
- Current Price ₹ 106
- High / Low ₹ 123 / 98.2
- Stock P/E 84.8
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 51.5 %
- ROE 51.2 %
- Face Value ₹ 2.00
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 43.5%
- Debtor days have improved from 229 to 138 days.
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| -0.00 | 4.77 | 40.24 | |
| 0.01 | 2.81 | 23.68 | |
| Operating Profit | -0.01 | 1.96 | 16.56 |
| OPM % | 41.09% | 41.15% | |
| -0.00 | 0.70 | 0.15 | |
| Interest | -0.00 | 0.07 | 0.65 |
| Depreciation | -0.00 | 0.32 | 3.29 |
| Profit before tax | -0.01 | 2.27 | 12.77 |
| Tax % | -0.00% | 24.67% | 25.53% |
| -0.01 | 1.71 | 9.50 | |
| EPS in Rs | -0.50 | 85.50 | 1.66 |
| Dividend Payout % | -0.00% | -0.00% | -0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 744% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 697% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 43% |
| Last Year: | 51% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Equity Capital | 0.20 | 0.20 | 11.37 |
| Reserves | 0.17 | 10.60 | 14.57 |
| -0.00 | 5.86 | 8.31 | |
| 3.50 | 3.86 | 21.09 | |
| Total Liabilities | 3.87 | 20.52 | 55.34 |
| -0.00 | 13.64 | 31.01 | |
| CWIP | -0.00 | -0.00 | -0.00 |
| Investments | -0.00 | -0.00 | -0.00 |
| 3.87 | 6.88 | 24.33 | |
| Total Assets | 3.87 | 20.52 | 55.34 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| -0.00 | 1.21 | 13.61 | |
| -0.00 | 0.22 | -18.14 | |
| -0.00 | -0.47 | 6.16 | |
| Net Cash Flow | -0.00 | 0.97 | 1.63 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Debtor Days | 321.38 | 137.51 | |
| Inventory Days | |||
| Days Payable | |||
| Cash Conversion Cycle | 321.38 | 137.51 | |
| Working Capital Days | 100.24 | -24.13 | |
| ROCE % | 19.26% | 51.52% |
Insights
In beta| Mar 2026 | |
|---|---|
| Acquired Ownership Stake - Ashwini Medical Centre % ・Standalone data |
|
| Acquired Ownership Stake - Harmony Medicare Private Limited % ・Standalone data |
|
| Acquired Ownership Stake - Parekhs Hospital Private Limited % ・Standalone data |
|
| Acquired Ownership Stake - Patel Multispeciality Hospital and ICU % ・Standalone data |
|
| Acquired Ownership Stake - Patel Pharmacy % ・Standalone data |
|
| Acquisition Cost - Ashwini Medical Centre INR ・Standalone data |
|
| Acquisition Cost - Harmony Medicare Private Limited INR ・Standalone data |
|
| Acquisition Cost - Parekhs Hospital Private Limited INR ・Standalone data |
|
| Acquisition Cost - Patel Multispeciality Hospital and ICU INR ・Standalone data |
|
| Acquisition Cost - Patel Pharmacy INR ・Standalone data |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
3 Mar - Company Secretary Mrs Niki Paresh Tiwari resigned; relieving date March 27, 2026; replacement process underway.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 17 Feb
-
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
15 Feb - NCLT allowed voluntary revision of Board's Report and notes for FY2021-22 to FY2023-24; RoC filing and Rs.10,000 fee.
-
Statement Of Deviation And Variation For Quarter Ended 31 Decembre 2025
15 Feb - No deviation in utilisation of Rs2,508,000,000 equity proceeds raised 24-12-2025.
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
14 Feb - Brickwork MA report (Dec 31, 2025): IPO proceeds Rs250.80cr; Rs50.04cr used; no deviations.
Annual reports
No data available.
Business Profile[1]
Gujarat Kidney and Super Speciality Limited is a regional healthcare operator in central Gujarat, running a chain of mid-sized multi-speciality hospitals focused on secondary and tertiary care.